The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection (Q40402518)

From Wikidata
Jump to navigation Jump to search
scientific article published on 20 December 2016
edit
Language Label Description Also known as
English
The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection
scientific article published on 20 December 2016

    Statements

    The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection (English)
    0 references
    William F Balistreri
    Karen F Murray
    Philip Rosenthal
    Sanjay Bansal
    Chuan-Hao Lin
    Kathryn Kersey
    Benedetta Massetto
    Yanni Zhu
    Bittoo Kanwar
    Polina German
    Evguenia Svarovskaia
    Diana M Brainard
    Jessica Wen
    Regino P Gonzalez-Peralta
    Maureen M Jonas
    Kathleen Schwarz
    20 December 2016
    371-378

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit